ArticleFrontiers in psychiatry2026
Correlation analysis of psychiatric and behavioral symptoms with cognitive impairment and prognosis in patients with general paresis.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the characteristics of neuropsychiatric symptoms (NPS) in patients with general paresis (GP) and analyze their correlation with cognitive impairment and prognosis. Methods: Clinical data from 100 GP patients admitted between January 2022 and June 2024 were retrospectively analyzed. Neuropsychiatric Inventory (NPI) assessed neuropsychiatric symptoms, while Mini-Mental State Examination (MMSE) evaluated cognitive function. All patients received standardized anti-syphilis treatment and completed 12-month follow-up. Based on cerebrospinal fluid test results at the final follow-up, patients were categorized into good and poor prognosis groups. Spearman correlation analysis explored the relationship between NPS and cognitive impairment, while multivariate logistic regression identified independent risk factors for poor prognosis. Results: All 100 patients exhibited varying degrees of NPS. The mean NPI total score was (42.38 ± 29.96) points, with depression (6.20 ± 3.83) and apathy (5.75 ± 3.78) scoring highest, while aberrant motor behavior (0.62 ± 1.08) scored lowest. All patients exhibited cognitive impairment, with a mean MMSE score of (13.78 ± 2.92). Impaired recall ability (0.94 ± 0.69) was the most significant deficit. Spearman correlation analysis revealed a significant negative correlation between NPI total scores and MMSE total scores (r = -0.583, P < 0.001). Additionally, all NPI subscales (e.g., delusions r = -0.573, appetite and eating changes r = -0.556) showed significant negative correlations with MMSE total scores (all P < 0.001). At the 12-month follow-up, 38 patients (38.00%) had a good prognosis, while 62 patients (62.00%) had a poor prognosis. Multivariate logistic regression analysis indicated that lower educational attainment (OR = 0.191, 95% CI: 0.052-0.709, P = 0.013), elevated baseline cerebrospinal fluid white blood cell count (OR = 3.194, 95% CI: 1.628-6.268, P<0.001), higher NPI total scores (OR = 1.073, 95% CI: 1.029-1.119, P<0.001), and lower MMSE scores (OR = 0.493, 95% CI: 0.338-0.720, P<0.001) were independent risk factors for poor prognosis in GP patients. Conclusion: The severity of psychiatric and behavioral symptoms showed a significant negative correlation with the degree of cognitive impairment. GP patients with low educational attainment, high baseline cerebrospinal fluid white blood cell counts, severe psychiatric and behavioral symptoms, and poor cognitive function had a higher risk of poor prognosis. Clinicians should develop targeted interventions addressing these high-risk factors to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.